← Back
Data updated: Mar 10, 2026
REVANCE THERAPEUTICS, INC.
ImmunologyDermatology
REVANCE THERAPEUTICS, INC. is a biotechnology company focused on Immunology, Dermatology.
2022
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 81%
0 drugs Phase 3: 5 Phase 2: 3
Dermatology 19%
0 drugs Phase 3: 1 Phase 2: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-09-07
- Latest
- 2023-08-11
- Applications
- 1